LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$734,857
-11.7%
7,811
-5.3%
0.01%
-11.1%
Q2 2023$832,005
+2.0%
8,245
-7.0%
0.01%0.0%
Q1 2023$816,040
-10.5%
8,870
-11.7%
0.01%
-18.2%
Q4 2022$911,284
+19.3%
10,0450.0%0.01%
+10.0%
Q3 2022$764,000
-17.4%
10,045
-8.2%
0.01%
-9.1%
Q2 2022$925,000
-11.6%
10,943
-8.2%
0.01%0.0%
Q1 2022$1,046,000
+0.7%
11,923
+0.4%
0.01%
+10.0%
Q4 2021$1,039,000
-9.4%
11,873
-15.4%
0.01%
-9.1%
Q3 2021$1,147,000
-20.2%
14,026
-11.0%
0.01%
-26.7%
Q2 2021$1,438,000
+8.1%
15,761
+1.3%
0.02%0.0%
Q1 2021$1,330,000
-27.7%
15,564
-20.1%
0.02%
-28.6%
Q4 2020$1,840,000
+0.5%
19,484
-7.5%
0.02%
-8.7%
Q3 2020$1,831,000
-4.1%
21,058
-3.7%
0.02%
-11.5%
Q2 2020$1,909,000
+10.9%
21,858
+4.7%
0.03%
-10.3%
Q1 2020$1,722,000
-15.3%
20,886
-2.7%
0.03%
+7.4%
Q4 2019$2,034,000
-27.6%
21,476
-33.6%
0.03%
-34.1%
Q3 2019$2,810,000
+3.3%
32,341
+8.6%
0.04%
+2.5%
Q2 2019$2,719,000
-20.2%
29,775
-16.0%
0.04%
-23.1%
Q1 2019$3,409,000
+0.3%
35,463
-10.5%
0.05%
-16.1%
Q4 2018$3,400,000
-3.7%
39,619
-3.3%
0.06%
+10.7%
Q3 2018$3,531,000
+9.6%
40,982
-3.9%
0.06%0.0%
Q2 2018$3,223,000
-28.8%
42,663
-23.8%
0.06%
-31.7%
Q1 2018$4,524,000
-31.2%
55,960
-28.6%
0.08%
-32.2%
Q4 2017$6,580,000
-11.2%
78,376
-9.2%
0.12%
-15.4%
Q3 2017$7,410,000
-0.8%
86,314
-1.6%
0.14%
-3.4%
Q2 2017$7,473,000
+9.2%
87,708
-4.8%
0.15%
+3.5%
Q1 2017$6,843,000
+1.4%
92,134
-0.5%
0.14%
-4.7%
Q4 2016$6,747,000
-9.0%
92,628
-1.3%
0.15%
-11.8%
Q3 2016$7,413,000
-12.0%
93,889
-8.1%
0.17%
-12.4%
Q2 2016$8,425,000
+8.6%
102,109
-4.7%
0.19%
+6.0%
Q1 2016$7,761,000
-20.0%
107,143
-5.0%
0.18%
-23.8%
Q4 2015$9,705,000
-16.1%
112,796
-4.1%
0.24%
-18.6%
Q3 2015$11,566,0000.0%117,6090.0%0.30%0.0%
Q2 2015$11,566,000
-1.4%
117,609
-1.2%
0.30%
-0.3%
Q1 2015$11,735,000
-46.8%
119,000
-50.0%
0.30%
+4.6%
Q4 2014$22,060,000
+95.0%
238,080
+98.1%
0.28%
-7.5%
Q3 2014$11,315,000
+3.7%
120,205
-0.2%
0.31%
+3.7%
Q2 2014$10,909,000
+3.0%
120,505
-3.3%
0.30%
+1.7%
Q1 2014$10,592,000
+4.8%
124,580
-0.9%
0.29%
+3.9%
Q4 2013$10,103,000
+4.7%
125,686
-0.1%
0.28%
-5.1%
Q3 2013$9,647,000
+6.3%
125,755
-2.0%
0.29%
+3.5%
Q2 2013$9,071,000128,2820.28%
Other shareholders
NOVARTIS A G shareholders Q3 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders